These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Chlamydia pneumoniae as a pathogenetic risk factor in the development of arteriosclerosis and its complications]. Nagornev VA; Mal'tseva SV; Seliverstova VG; Sokurenko GIu; Voskan'iants AN Arkh Patol; 2004; 66(2):52-60. PubMed ID: 15154386 [TBL] [Abstract][Full Text] [Related]
7. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? Campbell LA; Kuo CC Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006 [TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance. Neumann FJ Circulation; 2002 Nov; 106(19):2414-6. PubMed ID: 12417534 [No Abstract] [Full Text] [Related]
10. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials. Liu C; Waters DD Prog Cardiovasc Dis; 2005; 47(4):230-9. PubMed ID: 15991152 [TBL] [Abstract][Full Text] [Related]
11. [Chlamydia pneumoniae, atherosclerosis, and coronary disease]. Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076 [TBL] [Abstract][Full Text] [Related]
12. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Muhlestein JB; Anderson JL; Hammond EH; Zhao L; Trehan S; Schwobe EP; Carlquist JF Circulation; 1998 Feb; 97(7):633-6. PubMed ID: 9495296 [TBL] [Abstract][Full Text] [Related]
13. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. Fong IW J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750 [TBL] [Abstract][Full Text] [Related]
15. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease. Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042 [TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence. High KP Clin Infect Dis; 1999 Apr; 28(4):746-9. PubMed ID: 10825031 [TBL] [Abstract][Full Text] [Related]
17. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis. Liuba P; Pesonen E; Paakkari I Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417 [No Abstract] [Full Text] [Related]
18. Chronic infections and atherosclerosis. Kis Z; Burián K; Virók D; Kari G; Endrész V; Gönczöl E Acta Microbiol Immunol Hung; 2001; 48(3-4):497-510. PubMed ID: 11791347 [TBL] [Abstract][Full Text] [Related]
19. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929 [TBL] [Abstract][Full Text] [Related]
20. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. Ieven MM; Hoymans VY J Clin Microbiol; 2005 Jan; 43(1):19-24. PubMed ID: 15634945 [No Abstract] [Full Text] [Related] [Next] [New Search]